GZMB and neoplasm: We found Y111, but not CD3 Isotype or PD-L1 mAb could significantly enhance the secretions of IFNγ, TNFα, and granzyme B from the expanded Vγ2Vδ2 T cells in the presence of tumor cells (Figure 6A).